Suppr超能文献

HIV 感染者病毒载量抑制超过三年且 CD4 恢复不完全的长期死亡率:一项队列研究。

Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study.

机构信息

Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.

出版信息

BMC Infect Dis. 2010 Nov 2;10:318. doi: 10.1186/1471-2334-10-318.

Abstract

BACKGROUND

The mortality in patients with persistent low CD4 count despite several years of HAART with sustained viral suppression is poorly documented. We aimed to identify predictors for inadequate CD4 cell recovery and estimate mortality in patients with low CD4 count but otherwise successful HAART.

METHOD

In a nationwide cohort of HIV patients we identified all individuals who started HAART before 1 January 2005 with CD4 cell count ≤ 200 cells/μL and experienced three years with sustained viral suppression. Patients were categorized according to CD4 cell count after the three years suppressed period (≤ 200 cells/μL; immunological non-responders (INRs), >200 cells/μL; immunological responders (IRs)). We used logistic regression and Kaplan-Meier analysis to estimated risk factors and mortality for INRs compared to IRs.

RESULTS

We identified 55 INRs and 236 IRs. In adjusted analysis age > 40 years and > one year from first CD4 cell count ≤ 200 cells/μL to start of the virologically suppressed period were associated with increased risk of INR. INRs had substantially higher mortality compared to IRs. The excess mortality was mainly seen in the INR group with > one year of immunological suppression prior to viral suppression and injection drug users (IDUs).

CONCLUSION

Age and prolonged periods of immune deficiency prior to successful HAART are risk factors for incomplete CD4 cell recovery. INRs have substantially increased long-term mortality mainly associated with prolonged immunological suppression prior to viral suppression and IDU.

摘要

背景

尽管经过多年高效抗逆转录病毒治疗(HAART)并持续病毒抑制,仍有部分患者的 CD4 计数持续较低,死亡率较高,但相关数据报道较少。我们旨在确定 CD4 细胞恢复不足的预测因素,并评估 CD4 计数较低但 HAART 成功的患者的死亡率。

方法

在一项全国性的 HIV 患者队列研究中,我们确定了所有在 2005 年 1 月 1 日前开始 HAART、CD4 细胞计数≤200 个/μL 且经历三年持续病毒抑制的患者。根据抑制期结束后(≤200 个/μL;免疫无应答者(INRs)和>200 个/μL;免疫应答者(IRs))的 CD4 细胞计数对患者进行分类。我们使用逻辑回归和 Kaplan-Meier 分析来估计 INRs 与 IRs 相比的风险因素和死亡率。

结果

我们确定了 55 名 INRs 和 236 名 IRs。在调整分析中,年龄>40 岁和从首次 CD4 细胞计数≤200 个/μL 到开始病毒抑制期的时间>1 年与 INR 风险增加相关。INRs 的死亡率明显高于 IRs。在免疫抑制>1 年且随后病毒抑制的 INR 组和注射吸毒者(IDUs)中,这种超额死亡率更为明显。

结论

年龄和成功 HAART 前免疫缺陷持续时间延长是 CD4 细胞恢复不完全的危险因素。INRs 的长期死亡率显著增加,主要与病毒抑制前免疫抑制时间延长和 IDU 有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3e4/2988053/ac2cff7efe19/1471-2334-10-318-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验